PCSK9 inhibitors: current status and emerging frontiers in lipid control.
Agnello F, Mauro MS, Rochira C, Landolina D, Finocchiaro S, Greco A, Ammirabile N, Raffo C, Mazzone PM, Spagnolo M, Occhipinti G, Imbesi A, Giacoppo D, Capodanno D.
Agnello F, et al. Among authors: mauro ms.
Expert Rev Cardiovasc Ther. 2024 Jan-Mar;22(1-3):41-58. doi: 10.1080/14779072.2023.2288169. Epub 2023 Nov 28.
Expert Rev Cardiovasc Ther. 2024.
PMID: 37996219
Review.